1994•PubMedRequires access

Gd-DTPA: an alternative contrast medium for CT.

Aidan D. Quinn, Neil John O'Hare, Fintan J. Wallis, Graham F. Wilson

Open publisher page 76 citations

Abstract

OBJECTIVE: The purpose of this study was to demonstrate that gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) could be used as a contrast medium in CT as an alternative to iodine-based compounds. MATERIALS AND METHODS: Solutions of different concentrations of Gd-DTPA and iopromide were scanned in a tissue equivalent phantom and it was shown that Gd-DTPA caused 2.5 times the attenuation of an equimolar solution of iopromide. From these in vitro studies an in vivo dose of 0.5 mmol/kg Gd-DTPA was calculated to be equivalent to 50 ml iopromide 300. RESULTS: Pre- and postenhancement CT was performed in a volunteer using Gd-DTPA intravenously, and adequate enhancement occurred in intracranial vessels. CONCLUSION: Gd-DTPA can be used to provide enhancement during CT and might be of value in iodine-sensitive patients.

About this research paper

What this paper is about

OBJECTIVE: The purpose of this study was to demonstrate that gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) could be used as a contrast medium in CT as an alternative to iodine-based compounds. MATERIALS AND METHODS: Solutions of different concentrations of Gd-DTPA and iopromide were scanned in a tissue equivalent phantom and it was shown that Gd-DTPA caused 2.5 times the attenuation of an equimolar solution of iopromide. From these in vitro studies an in vivo dose of 0.5 mmol/kg Gd-DTPA was calculated to be equivalent to 50 ml iopromide 300. RESULTS: Pre- and postenhancement CT was performed in a volunteer using Gd-DTPA intravenously, and adequate enhancement occurred in intracranial vessels. CONCLUSION: Gd-DTPA can be used to provide enhancement during CT and might be of value in iodine-sensitive patients.

Why it matters

OpenAlex reports 76 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: The purpose of this study was to demonstrate that gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) could be used as a contrast medium in CT as an alternative to iodine-based compounds. MATERIALS AND METHODS: Solutions of different concentrations of Gd-DTPA and iopromide were scanned in a tissue equivalent phantom and it was shown that Gd-DTPA caused 2.5 times the attenuation of an equimolar solution of iopromide. From these in vitro studies an in vivo dose of 0.5 mmol/kg Gd-DTPA was calculated to be equivalent to 50 ml iopromide 300. RESULTS: Pre- and postenhancement CT was performed in a volunteer using Gd-DTPA intravenously, and adequate enhancement occurred in intracranial vessels. CONCLUSION: Gd-DTPA can be used to provide enhancement during CT and might be of value in iodine-sensitive patients.

Key concepts: Iopromide, Medicine, Gadolinium, Contrast medium, Iodine, Nuclear medicine, Diethylenetriamine, Imaging phantom

Related papers

Back to paper searchBrowse research topicsOriginal source
Gd-DTPA: an alternative contrast medium for CT. — Research Paper | ScholarLens